Skip to main content

VivoSim Labs, INC.

VIVS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001497253

In the last 90 days, VivoSim Labs, INC. insiders filed 1 open-market purchase and 0 sales; 25 institutions reported holding it in 13F filings for Q2 2026, worth $109.7K in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding VivoSim Labs, INC. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of VIVS: Q3 2021 compared with Q4 2021
MeasureQ3 2021Of which not filed for Q4 2021Q4 2021Change
Holders43148+6
Shares2.19M2252.27M+72.9K (+3.3%)
Value$14.9M$2.00K$8.23M−$6.67M (−44.8%)

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (13)

Institutions that held VivoSim Labs, INC. at the end of Q4 2021 but not at the end of Q3 2021.

Sold out (7)

Institutions that held VivoSim Labs, INC. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of VIVS in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Millennium Management LLC13,809$94.0K
Commonwealth Equity Services, LLC12,292$83.0K
Quattro Financial Advisors LLC11,000$72.0K
Arkadios Wealth Advisors2,400$16.0K
Spire Wealth Management1,000$7.00K
Tortoise Investment Management, LLC18$0
Community Bank, N.A.5$0

Not filed for Q4 2021 yet (1)

Institutions that held VivoSim Labs, INC. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding VIVS in Q3 2021 that haven't filed for Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Wealth Quarterback LLC225$2.00K